CJC-1295 (± DAC)

Evidence: ★★★☆☆ · Status: Not Approved

In plain English

A longer-lasting GH releaser. Usually paired with ipamorelin so one raises the "how much" and the other the "release now."

How it works

Long-acting GHRHR agonist; the DAC (drug-affinity complex) version binds albumin for a multi-day half-life, giving a sustained GH "bleed" rather than a pulse.

Molecular target & official sources

GHRHR (NCBI Gene) · CJC-1295 (PubChem CID 91976842)

Bottom line

Common half of the "CJC + ipamorelin" stack.

Helps with: Hormones & Testosterone

Availability & where to buy

Not widely approved. Not approved for general sale in most markets (Singapore included). Grey-market only — dose, purity and legality uncertain.